HealthCor Management’s Amgen AMGN Stock Holding History

HealthCor Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,370	Closed	-$17M	–	27
2022 Q3	$17M	Buy	+75,370	New	+$18.3M	2.12%	19
2022 Q2	–	Sell	-108,890	Closed	-$26.3M	–	61
2022 Q1	$26.3M	Buy	108,890 +46,400	+74%	+$10.7M	1.76%	27
2021 Q4	$14.1M	Buy	+62,490	New	+$13.2M	0.77%	39
2021 Q3	–	Sell	-158,280	Closed	-$38.6M	–	74
2021 Q2	$38.6M	Buy	+158,280	New	+$38.9M	1.54%	24
2020 Q4	–	Sell	-233,740	Closed	-$59.4M	–	56
2020 Q3	$59.4M	Sell	233,740 -25,460	-10%	-$6.31M	2.38%	19
2020 Q2	$61.1M	Buy	+259,200	New	+$59.1M	2.56%	17
2018 Q3	–	Sell	-51,510	Closed	-$9.51M	–	42
2018 Q2	$9.51M	Buy	+51,510	New	+$9.11M	0.3%	43
2016 Q1	–	Sell	-2,250	Closed	-$365K	–	42
2015 Q4	$365K	Buy	+2,250	New	+$354K	0.02%	41

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HealthCor Management's AMGN Position: Q4 2022 in Review

HealthCor Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 75,370 shares — an estimated $17M sold.

HealthCor Management first reported a position in AMGN in Q4 2015 and held it in 8 quarters. The position peaked at $61.1M in Q2 2020. 2,502 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

HealthCor Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
HealthCor Management sold 75,370 Amgen shares in Q4 2022, an estimated $17M.
HealthCor Management first reported a position in Amgen in Q4 2015 and held it in 8 quarters.
HealthCor Management's Amgen position peaked at $61.1M in Q2 2020.
2,502 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.